Categories
Topics

“Finally, biologists can directly see what they're studying” Yann Cotte

Deactivate selection mode Select images

The selection mode is now active. Click on the images you wish to download and choose an action below

EPFL spin-off Nanolive has developed a microscope that lets scientists look inside live cells – a feature particularly useful for new drug discovery. Founded by CEO Yann Cotte ten years ago, the firm has just opened a regional office in the US with the goal of going public. EPFL spin-off Nanolive has developed a microscope that lets scientists look inside live cells – a feature particularly useful for new drug discovery. Founded by CEO Yann Cotte ten years ago, the firm has just opened a regional office in the US with the goal of going public. EPFL spin-off Nanolive has developed a microscope that lets scientists look inside live cells – a feature particularly useful for new drug discovery. Founded by CEO Yann Cotte ten years ago, the firm has just opened a regional office in the US with the goal of going public. EPFL spin-off Nanolive has developed a microscope that lets scientists look inside live cells – a feature particularly useful for new drug discovery. Founded by CEO Yann Cotte ten years ago, the firm has just opened a regional office in the US with the goal of going public.